Daily update on share prices and consensus price targets.

By Rudi Filapek-Vandyck

Cochlear ((COH)) has remained on many an investors' radar since the company had to announce a recall of its top product, with the main question being asked whether the subsequent drop in share price has created a buying opportunity, or not?

The jury's still out on that one and it probably very much depends on what price level we're adding to the question. Since peaking above $80 (before recall announcement) Cochlear shares have traded close to $45 and as high as $64. In recent sessions weakness has started to kick in which, in Icarus terms, has pushed the share price back under the consensus price target, currently at $59.81.

It looks like the shares are finding it increasingly difficult to withstand gravity